ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0971

Development of a Theory-based Educational Intervention for Fatigue in Systemic Lupus Erythematosus (SLE) Using Human-centered Design Methodology

Shanthini Kasturi1, Stephanie Tate2, Thomas Farrar3, Lisa Mandl4, Amy LeClair1, Faye Chiu5, Monique Gore-Massy6, Iris Navarro-Millan7 and Sara Folta8, 1Tufts Medical Center, Boston, MA, 2Tufts University School of Medicine, Boston, MA, 3Tufts University School of Medicine, Portland, 4Hospital for Special Surgery, New York, NY, 5N/A, New York, NY, 6Covid-19 GRA, West Orange, NJ, 7Weill Cornell Medicine, New York, NY, 8Tufts University, Boston, MA

Meeting: ACR Convergence 2022

Keywords: education, patient, Fatigue, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Research Methodology Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Fatigue is a top concern of individuals with SLE and is a leading cause of work impairment and disability in this population. Although fatigue affects over 90% of patients with SLE over the course of their illness, it is often not systematically addressed during medical visits. Both patients and physicians cite a need for patient support, including information on the drivers of fatigue and self-management strategies. To address this gap, we developed a theory-based patient-centered educational intervention focused on fatigue in patients with SLE

Methods: The educational intervention was developed using human-centered design methodology by a multi-disciplinary team including two patient stakeholders. Patient perspectives and needs around managing fatigue in SLE were explored in the “inspiration” phase through literature review, focus groups, and informal conversations with patients. In the “ideation” phase, barriers in fatigue knowledge and skills were identified and formulated as questions from the patient perspective. Questions were iteratively refined with the input of the patient stakeholders and organized into modules that defined the scope of the educational intervention. Modules consisted of evidence-based answers to the patient-oriented questions and incorporated: 1) core principles of adult education, including discrete learning objectives and self-assessment questions and 2) constructs from the self-determination theory of motivation, emphasizing autonomy, competence, and relatedness. They were presented as infographics, using plain language with attention to health literacy. Modules were reviewed in in-depth interviews and surveys by patients with SLE, purposefully sampled around age, sex, race, ethnicity, and disease duration. Interviews were recorded, transcribed, and analyzed using a rapid analysis protocol and feedback capture grid.

Results: An educational intervention covering four topics with over twenty patient-oriented questions was developed and iteratively refined with the input of patient stakeholders. Topics included: 1) Fatigue and Lupus; 2) Managing Fatigue in Lupus (Fatigue Modules); 3) Physical Activity and Lupus; and 4) Moving More with Lupus (Physical Activity Modules). Ten individuals with SLE (Table 1) provided feedback on the intervention. Participants rated the modules positively and were highly likely to recommend them to others with lupus (Table 2). They praised the clarity, engaging tone, and graphics of the modules and suggested adding emphasis on pacing and validation of fear related to exercise, and creating options for variable color schemes and translation into multiple languages for different audiences (Figure 1).

Conclusion: We developed a theory-based educational intervention addressing fatigue in SLE using a patient-engaged, human-centered design approach. Feedback obtained from the “ideation” phase will inform intervention refinement and pilot testing (“implementation”) to assess efficacy in improving knowledge, skills, and fatigue in individuals living with SLE.

Supporting image 1

Table 1. Socio-demographic characteristics of interview participants (n=10)

Supporting image 2

Table 2. Patient Ratings of Educational Materials

Supporting image 3

Figure 1. Educational Modules Feedback Capture Grid


Disclosures: S. Kasturi, GlaxoSmithKlein(GSK); S. Tate, None; T. Farrar, None; L. Mandl, Pfizer; A. LeClair, None; F. Chiu, None; M. Gore-Massy, Aurinia Pharmaceuticals, Janssen, Bristol-Myers Squibb(BMS); I. Navarro-Millan, Sweden Orphan Biovitrum (SOBI); S. Folta, None.

To cite this abstract in AMA style:

Kasturi S, Tate S, Farrar T, Mandl L, LeClair A, Chiu F, Gore-Massy M, Navarro-Millan I, Folta S. Development of a Theory-based Educational Intervention for Fatigue in Systemic Lupus Erythematosus (SLE) Using Human-centered Design Methodology [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/development-of-a-theory-based-educational-intervention-for-fatigue-in-systemic-lupus-erythematosus-sle-using-human-centered-design-methodology/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-theory-based-educational-intervention-for-fatigue-in-systemic-lupus-erythematosus-sle-using-human-centered-design-methodology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology